SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-074127
Filing Date
2024-06-24
Accepted
2024-06-24 07:22:42
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm2417848-1_424b5.htm 424B5 542122
2 GRAPHIC bc_muscle-4c.jpg GRAPHIC 53284
3 GRAPHIC lc_pharmacokinetics-4c.jpg GRAPHIC 40203
4 GRAPHIC lg_entradatherapeutic-4clr.jpg GRAPHIC 45877
5 GRAPHIC tb_treatment-4clr.jpg GRAPHIC 56868
  Complete submission text file 0001104659-24-074127.txt   809798
Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Filer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-268099 | Film No.: 241062051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)